- 2.Remembering Nolan Williams, M.D. (maps.org)
- 10.After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data (psychedelicalpha.com)
- 11.Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts (psychedelicalpha.com)
- 12.Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast (psychedelicalpha.com)
- 13.The State of the Psychedelic Industry & Open Questions (Video) (psychedelicalpha.com)
- 14.Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials (psychedelicalpha.com)
- 17.AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal (psychedelicalpha.com)
- 18.February 2026 Psychedelic Bill Round-up (psychedelicalpha.com)